Endpoints for homocysteine-lowering trials

Lancet

Volumn 355, Issue 9203, 2000, Pages 511-512

  Bostom, Andrew G ^a   Garber, Carol ^b  

^a MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^b Hope Hospice and Palliative Care Rhode Island   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

AMINO ACID BLOOD LEVEL; ARTERIOSCLEROSIS; ARTERY BLOOD FLOW; CARDIOVASCULAR DISEASE; CAROTID ARTERY; DIET RESTRICTION; DOPPLER FLOWMETRY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMORAL ARTERY; HUMAN; HYPERHOMOCYSTEINEMIA; NOTE; PRIORITY JOURNAL;

EID: 0034639642     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00437-7     Document Type: Note

References (13)

1. Mudd S.H., Skovby F., Levy H.L.et al. Natural history of homocystinuria due to cystathionine beta synthase deficiency. Am J Hum Genet. 37:1985;1-25.
2. Omenn G.S., Beresford S.A.A., Motulsky A.G. Preventing coronary heart disease: B vitamins and homocysteine. Circulation. 97:1998;421-424.
3. Bostom A.G., Rosenberg I.H., Silbershatz H.et al. Nonfasting plasma total homocysteine and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med. 131:1999;352-355.
4. Bostom A.G. Homocysteine: "expensive creatinine", or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients? J Amer Soc Nephrol. 11:2000;149-151.
5. Taylor L.M. Jr., Moneta G.L., Sexton G.J., Schuff R.A., Porter J.M. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral vascular disease. J Vasc Surg. 29:1999;8-19.
6. Malinow M.R., Nieto F.J., Szklo M., Chambless L.E., Bond M.G. Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Circulation. 87:1993;1107-1113.
7. McQuillan B.M., Beilby J.P., Nidorf M., Thompson P.L., Hung J. The risk of carotid atherosclerosis with hyperhomocysteinaemia and the C677T mutation of methylenetetrahydrofolate reductase. The Perth Carotid Ultrasound Assessment Study (CUDAS). Circulation. 99:1999;2383-2388.
8. Froelicher V.F., Fearon W.F., Ferguson C.M.et al. Lessons learned from studies of the standard exercise ECG test. Chest. 116:1999;1442-1451.
9. Adams M.R., Nakagomi A., Keech A.et al. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation. 92:1995;2127-2134.
10. Probstfield J.L., Byington R.P., Egan D.Aet al. Methodological issues facing studies of atherosclerotic change. Circulation. 87:1993;74-181.
11. Clarke R., Collins R. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease. J Cardiovasc Risk. 5:1998;249-255.
12. Malinow M.R., Bostom A.G., Krauss R.M. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 99:1999;1787-1882.
13. Jacques P.F., Selhub J., Bostom A.G., Wilson P.W.F., Rosenberg I.H. Impact of folic acid fortification on plasma folate and total homocysteine concentrations in middle-aged and older adults from the Framingham Study. N Engl J Med. 340:1999;1449-1454.